Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?

Recently, an increasing number of novel drugs were approved in oncology and hematology. Nevertheless, pharmacology progress comes with a variety of side effects, of which cytokine release syndrome (CRS) is a potential complication of some immunotherapies that can lead to multiorgan failure if not di...

Descripción completa

Detalles Bibliográficos
Autores principales: Constantinescu, Catalin, Pasca, Sergiu, Tat, Tiberiu, Teodorescu, Patric, Vlad, Catalin, Iluta, Sabina, Dima, Delia, Tomescu, Dana, Scarlatescu, Ecaterina, Tanase, Alina, Sigurjonsson, Olafur Eysteinn, Colita, Anca, Einsele, Hermann, Tomuleasa, Ciprian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264828/
https://www.ncbi.nlm.nih.gov/pubmed/32474415
http://dx.doi.org/10.1136/jitc-2020-000742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264828/
https://www.ncbi.nlm.nih.gov/pubmed/32474415
http://dx.doi.org/10.1136/jitc-2020-000742

Ejemplares similares